Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002064832-25-000013
Filing Date
2025-11-03
Accepted
2025-11-03 17:25:00
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 12637
  Complete submission text file 0002064832-25-000013.txt   14194
Mailing Address C/O ORGANOGENESIS HOLDINGS INC. 85 DAN ROAD CANTON MA 02021
Business Address
NUSSDORF GLENN H (Reporting) CIK: 0001244191 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37906 | Film No.: 251445306

Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Issuer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)